Frederick M Aono

Title: Frederick M Aono: Innovator in Dendritic Cell Culture

Introduction

Frederick M Aono is a notable inventor based in Arlington Hills, IL (US). He has made significant contributions to the field of immunology, particularly in the culture of dendritic cells for therapeutic applications. His innovative methods have the potential to advance treatments for various diseases, including cancer and infections.

Latest Patents

Aono holds a patent for a groundbreaking method titled "Cytokine-free culture of dendritic cells." This invention allows for the production of human dendritic cells without the use of cytokines, or with reduced cytokine levels. The method involves culturing mononuclear cells from blood or bone marrow in a specialized medium containing agents such as calcium ionophore A23187, theophylline, and Vitamin D3. The culture is maintained for a period of 4-14 days, resulting in an enriched population of dendritic cells, which can be identified by specific markers.

Career Highlights

Frederick M Aono is associated with Nexell Therapeutics Inc., where he continues to develop innovative solutions in the field of cell therapy. His work focuses on enhancing the efficacy of dendritic cells for therapeutic purposes, which can be pivotal in treating viral infections and cancer.

Collaborations

Aono has collaborated with notable colleagues, including Mona Vachula and Dennis E Van Epps. These partnerships have contributed to the advancement of research and development in dendritic cell therapies.

Conclusion

Frederick M Aono's contributions to the field of immunology through his innovative patent on dendritic cell culture highlight his role as a significant inventor. His work has the potential to impact therapeutic strategies for various diseases, showcasing the importance of innovation in medical science.